Aster Aqueous Extract for Multi-Target Acne Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current acne treatments primarily target single aspects of acne etiology, such as sebum overproduction, bacterial proliferation, or inflammation, and are ineffective against multi-resistant bacteria, leading to a need for a comprehensive approach that addresses all causes of acne and reduces bacterial resistance.

Innovation Solution

An aqueous extract derived from the aerial parts of Aster plants, particularly Aster alpinus and Aster tataricus, is used to inhibit the proliferation of Cutibacterium acnes and Staphylococcus aureus, and reduce IL-1β-stimulated IL-6 production, utilizing an extraction method without organic solvents to maintain a natural and non-toxic composition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional acne treatments target single aspects (sebum reduction, bacterial proliferation control, or inflammation reduction), then specific treatment goals are achieved, but comprehensive effectiveness against multi-factorial acne etiology is insufficient

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidmulti-target capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies the universality principle by utilizing a single natural extract (propolis) that simultaneously performs multiple functions: it reduces sebum production, inhibits bacterial proliferation (including multi-resistant strains), and reduces inflammation. This multi-functional approach addresses all three main aspects of acne etiology with one treatment agent, thereby achieving comprehensive effectiveness while maintaining treatment simplicity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Productivity

If antibiotic treatments are used to reduce bacterial proliferation, then short-term bacterial control is achieved, but bacterial resistance develops over time

Engineering Contradiction:
Improvebacterial proliferation controlVSAvoidlong-term effectiveness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies this principle by using a natural extract (propolis) that acts as a disposable, non-persistent antimicrobial agent. Unlike antibiotics that exert selective pressure leading to resistance, the complex mixture of compounds in propolis provides broad-spectrum antimicrobial activity without promoting resistance development. The extract effectively controls bacterial proliferation including multi-resistant strains while maintaining long-term treatment reliability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Object-affected harmful factors

If general anti-inflammatory agents are used to reduce inflammation, then inflammation is suppressed, but specificity and side effect profile are poor

Engineering Contradiction:
Improveinflammation reductionVSAvoidside effects
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent applies the local quality principle by using propolis, a natural extract with specific anti-inflammatory properties that act locally on acne-related inflammation without the systemic side effects of general anti-inflammatory agents. The extract targets inflammatory pathways specifically involved in acne pathogenesis while maintaining a favorable safety profile, thereby reducing harmful effects without generating significant side effects.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20260061016A1Extrait aqueux des parties aériennes d'une plante du genre Aster et ses utilisations
Publication Date: 2026.03.05 TAUDERMA
  • US20260061016A1 patent drawing

AI summary

The present invention relates to an aqueous extract obtained from a plant of the genus Aster for cosmetic or therapeutic applications, in particular in the prevention and/or treatment of acne.